RE.DOCTOR

Curated by Signal

AI-based vital signs and blood glucose screening tool

Overview

AI-based vital signs and blood glucose screening tool. The company has developed a transdermal optical imaging app that uses the camera on a smartphone to gather vital signs and blood glucose data. It comes with features for health analysis, telehealth monitoring, and remote health analysis.

Key facts

Founded: 2022
Headquarters: Sheridan, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

12 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

LH surge
Developer of luteinizing hormone monitoring device
Life Sciences TechnologyTennessee, United States
Phylos Bioscience
Developer of cannabis breeding tools for agriculture & other health purposes
Life Sciences TechnologyPortland, United States
NatPro Pharmaceutical
Developer of chemotherapeutic drugs for the treatment of cancer
Life Sciences TechnologyBrookings, United States

About RE.DOCTOR

What does RE.DOCTOR do?

AI-based vital signs and blood glucose screening tool.

Where is RE.DOCTOR headquartered?

RE.DOCTOR is headquartered in Sheridan, United States.

When was RE.DOCTOR founded?

RE.DOCTOR was founded in 2022.

Which sector is RE.DOCTOR in?

RE.DOCTOR operates in Life Sciences Technology.

Who are RE.DOCTOR's competitors?

Companies similar to RE.DOCTOR include LH surge, Phylos Bioscience, and NatPro Pharmaceutical.